Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05413915
Title Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sarit Assouline
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.